151 related articles for article (PubMed ID: 36263182)
1. Traditional Chinese Medicine JingYinGuBiao Formula Therapy Improves the Negative Conversion Rate of SARS-CoV2 in Patients with Mild COVID-19.
Chen B; Geng P; Shen J; Liangpunsakul S; Lyu H; Zhang J; Yang Y; Zhang L; Xu Y; Dong C; Wang Y; Xue Y; Zhang W; Liu H; Li M; Gao Y
Int J Biol Sci; 2022; 18(15):5641-5652. PubMed ID: 36263182
[No Abstract] [Full Text] [Related]
2. Clinical efficacy of Jingyin granules, a Chinese patent medicine, in treating patients infected with coronavirus disease 2019.
Chen B; Yu X; Zhang L; Huang W; Lyu H; Xu Y; Shen J; Yuan W; Fang M; Li M; Gao Y
Phytomedicine; 2023 Jan; 108():154496. PubMed ID: 36288651
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
[TBL] [Abstract][Full Text] [Related]
4. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Chinese medicine formula Huashibaidu granule on mild COVID-19 patients: A prospective, non-randomized, controlled trial.
Chen B; Xue Y; Jing H; Wang X; Zhu P; Hao W; Li M; Gao Y
Integr Med Res; 2023 Jun; 12(2):100950. PubMed ID: 37192979
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial.
Hosogaya N; Miyazaki T; Fukushige Y; Takemori S; Morimoto S; Yamamoto H; Hori M; Kurokawa T; Kawasaki Y; Hanawa M; Fujii Y; Hanaoka H; Iwami S; Watashi K; Yamagoe S; Miyazaki Y; Wakita T; Izumikawa K; Yanagihara K; Mukae H; Kohno S;
Trials; 2021 Apr; 22(1):309. PubMed ID: 33910617
[TBL] [Abstract][Full Text] [Related]
8. Traditional Chinese Medicine Formulation Therapy in the Treatment of Coronavirus Disease 2019 (COVID-19).
Shi J; Lu Y; Zhang Y; Xia L; Ye C; Lü Y; Chen S; Xu Q; Tang B; Yin K; Zhang J; Chen X; Yang Z
Am J Chin Med; 2020; 48(7):1523-1538. PubMed ID: 33148005
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Huashi Baidu Granules in Treating Patients with SARS-CoV-2 Omicron Variant: A Single-Center Retrospective Cohort Study.
Chen CY; Zhang W; Xu XR; Pu YT; Tu YD; Peng W; Yao X; Zhou S; Fang BJ
Chin J Integr Med; 2024 Feb; 30(2):107-114. PubMed ID: 37222827
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2.
Ma Q; Xie Y; Wang Z; Lei B; Chen R; Liu B; Jiang H; Wang Y; Liu Q; Yang Z
J Ethnopharmacol; 2021 Oct; 279():114367. PubMed ID: 34174375
[TBL] [Abstract][Full Text] [Related]
11. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.
Vallejos J; Zoni R; Bangher M; Villamandos S; Bobadilla A; Plano F; Campias C; Chaparro Campias E; Achinelli F; Guglielmone HA; Ojeda J; Medina F; Farizano Salazar D; Andino G; Ruiz Diaz NE; Kawerin P; Meza E; Dellamea S; Aquino A; Flores V; Martemucci CN; Vernengo MM; Martinez SM; Segovia JE; Aguirre MG
Trials; 2020 Nov; 21(1):965. PubMed ID: 33234158
[TBL] [Abstract][Full Text] [Related]
12. Timely treatment and higher compliance to traditional Chinese medicine: New influencing factors for reducing severe COVID-19 based on retrospective cohorts in 2020 and 2021.
Zhang Y; Liu Y; Li M; Feng S; Li X; Gao Z; Yang Y; Tong X
Pharmacol Res; 2022 Apr; 178():106174. PubMed ID: 35288309
[TBL] [Abstract][Full Text] [Related]
13. Effects of Tanreqing Capsule on the negative conversion time of nucleic acid in patients with COVID-19: A retrospective cohort study.
Zhang X; Xue Y; Chen X; Wu JM; Su ZJ; Sun M; Liu LJ; Zhang YB; Zhang YL; Xu GH; Shi MY; Song XM; Lu YF; Chen XR; Zhang W; Chen Q
J Integr Med; 2021 Jan; 19(1):36-41. PubMed ID: 33069626
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety assessment of severe COVID-19 patients with Chinese medicine: A retrospective case series study at early stage of the COVID-19 epidemic in Wuhan, China.
Wang Y; Lu C; Li H; Qi W; Ruan L; Bian Y; Shi H; Song H; Tu S; Zhang Y; Bai T; Cao R; Hong K; Li H; Liu L; Lu S; Rong N; Liu Y; Fang J; Shi J; Yang W; Zhao B; Yang Y; Zhao Y; Li S; Fan T; Rong P; Huang L
J Ethnopharmacol; 2021 Sep; 277():113888. PubMed ID: 33529638
[TBL] [Abstract][Full Text] [Related]
15. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
16. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
17. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
[TBL] [Abstract][Full Text] [Related]
18. A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial.
Takayama S; Namiki T; Ito T; Arita R; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Kainuma M; Nochioka K; Takagi A; Mimura M; Yamaguchi T; Ishii T
Trials; 2020 Oct; 21(1):827. PubMed ID: 33008479
[TBL] [Abstract][Full Text] [Related]
19. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of Reyanning mixture in patients infected with SARS-CoV-2 Omicron variant: A prospective, open-label, randomized controlled trial.
Xu X; Zhou S; Chen C; Li J; Wu H; Jin G; Zhou J; Wang G; Cao M; Sun D; Zhang W; Peng W; Pu Y; Sun Y; Fang B; Xu J
Phytomedicine; 2023 Jan; 108():154514. PubMed ID: 36334390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
